IMMUNO-COV™ – The Test for Antibodies that Block SARS-CoV-2 Infection Read More

June 3-7, 2022

American Society of Clinical Oncology Annual Meeting (ASCO)

Luke Russell, Ph.D., Vyriad Director of Alliance Management and Alice Bexon, M.D., Vyriad Chief Medical Officer. Poster Presentation:  Jose Lutzky, M.D., University of Miami Health System. VV1 oncolytic virus + cemiplimab + Ipilimumab in patients with melanoma or NSCLC

Visit event site

Media Inquiries

For inquiries, please contact mediarelations@vyriad.com